Security key
221015100
Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS)
CUSIP: 221015100
Q2 2020 13F Holders as of 30 Jun 2020
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 91,091,040
- Total 13F shares
- 20,440,680
- Share change
- -176,384
- Total reported value
- $55,598,011
- Price per share
- $2.72
- Number of holders
- 34
- Value change
- -$392,205
- Number of buys
- 12
- Number of sells
- 13
Report period
Q2 2020
Institutions
34
Top holders
10
CRVS full security history
Newer quarter: Q3 2020
Previous quarter: Q1 2020
Corvus Pharmaceuticals, Inc. SEC filings
Corvus Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 221015100
Recent filing periods:
Top shareholders of CRVS - Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
7.4%
|
6,767,584
|
$14,280,000 | — | 31 Mar 2020 | |
| ADAMS STREET PARTNERS LLC |
13F
|
Company |
3.6%
|
3,275,616
|
$6,912,000 | — | 31 Mar 2020 | |
| Novo Holdings A/S |
13F
|
Company |
3.2%
|
2,927,560
|
$6,177,000 | — | 31 Mar 2020 | |
| BVF INC/IL |
13F
|
Company |
2.4%
|
2,156,740
|
$4,551,000 | — | 31 Mar 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.1%
|
1,031,759
|
$2,177,000 | — | 31 Mar 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1%
|
930,700
|
$1,964,000 | — | 31 Mar 2020 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.81%
|
737,612
|
$1,556,000 | — | 31 Mar 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.63%
|
574,088
|
$1,212,000 | — | 31 Mar 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.48%
|
438,383
|
$925,000 | — | 31 Mar 2020 | |
| CHI Advisors LLC |
13F
|
Company |
0.4%
|
364,132
|
$768,000 | — | 31 Mar 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.35%
|
315,277
|
$664,000 | — | 31 Mar 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
138,916
|
$293,000 | — | 31 Mar 2020 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
133,700
|
$282,000 | — | 31 Mar 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.13%
|
117,606
|
$248,000 | — | 31 Mar 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.12%
|
112,065
|
$236,000 | — | 31 Mar 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.11%
|
99,258
|
$209,000 | — | 31 Mar 2020 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.09%
|
85,604
|
$181,000 | — | 31 Mar 2020 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.09%
|
78,576
|
$166,000 | — | 31 Mar 2020 | |
| Hikari Power Ltd |
13F
|
Company |
0.07%
|
60,959
|
$129,000 | — | 31 Mar 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
45,262
|
$95,000 | — | 31 Mar 2020 | |
| Puissance Capital Management LP |
13F
|
Company |
0.04%
|
38,010
|
$80,000 | — | 31 Mar 2020 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.04%
|
34,709
|
$73,000 | — | 31 Mar 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.04%
|
32,920
|
$69,000 | — | 31 Mar 2020 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.03%
|
30,220
|
$63,000 | — | 31 Mar 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.03%
|
28,880
|
$61,000 | — | 31 Mar 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
26,852
|
$57,000 | — | 31 Mar 2020 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.03%
|
24,436
|
$52,000 | — | 31 Mar 2020 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.02%
|
16,947
|
$36,000 | — | 31 Mar 2020 | |
| RAYMOND JAMES TRUST N.A. |
13F
|
Company |
0.01%
|
13,158
|
$28,000 | — | 31 Mar 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
4,017
|
$8,000 | — | 31 Mar 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
3,619
|
$8,000 | — | 31 Mar 2020 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,816
|
$6,000 | — | 31 Mar 2020 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
1,780
|
$4,000 | — | 31 Mar 2020 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
1,000
|
$2,000 | — | 31 Mar 2020 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
608
|
$1,000 | — | 31 Mar 2020 | |
| FMR LLC |
13F
|
Company |
0%
|
400
|
$1,000 | — | 31 Mar 2020 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
79
|
$167 | — | 31 Mar 2020 |
Institutional Holders of Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) as of Q2 2020
As of 30 Jun 2020,
Corvus Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (CRVS) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,440,680 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, ADAMS STREET PARTNERS LLC, NOVO Holdings A/S, BVF INC/IL, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, and CHI Advisors LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2020 vs Q1 2020 Across Filers
Q1 2020 holders
36
Q2 2020 holders
34
Holder diff
-2
| Investor | Q1 2020 Shares | Q2 2020 Shares | Share Diff | Share Chg % | Q1 2020 Value $ | Q2 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.